These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35179953)

  • 1. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.
    Kamerkar S; Leng C; Burenkova O; Jang SC; McCoy C; Zhang K; Dooley K; Kasera S; Zi T; Sisó S; Dahlberg W; Sia CL; Patel S; Schmidt K; Economides K; Soos T; Burzyn D; Sathyanarayanan S
    Sci Adv; 2022 Feb; 8(7):eabj7002. PubMed ID: 35179953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer.
    Chen Y; Gong L; Cao Y; Liu Z; Wang Y; Cheng H; Feng Y; Yao S; Yin Y; Wu Z; Huang Z
    J Control Release; 2024 Feb; 366():395-409. PubMed ID: 38184235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-mediated PLGA-PEI Nanobubbles Carrying STAT6 SiRNA Enhances NSCLC Treatment
    Shu H; Lv W; Ren ZJ; Li H; Dong T; Zhang Y; Nie F
    Curr Drug Deliv; 2024; 21(8):1114-1127. PubMed ID: 37491853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major vault protein regulates tumor-associated macrophage polarization through interaction with signal transducer and activator of transcription 6.
    Yu C; Zhu Q; Ma C; Luo C; Nie L; Cai H; Wang Q; Wang F; Ren H; Yan H; Xu K; Zhou L; Zhang C; Lu G; Lu Z; Zhu Y; Liu S
    Front Immunol; 2023; 14():1289795. PubMed ID: 38264642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
    Jayaseelan VP; Paramasivam A
    Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
    Binnemars-Postma K; Bansal R; Storm G; Prakash J
    FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHISA3 Reprograms Tumor-Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy.
    Zhang S; Yu B; Sheng C; Yao C; Liu Y; Wang J; Zeng Q; Mao Y; Bei J; Zhu B; Chen S
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403019. PubMed ID: 39054639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel targeted iron oxide nanocarrier for inhibiting M2-type macrophages in the tumor microenvironment.
    Tian K; Feng R; Wang X; Wu X; Li L; Liu W; Wu R
    J Cancer Res Ther; 2022 Sep; 18(5):1409-1416. PubMed ID: 36204890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 Oct; 81(4):690-703. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
    Chen W; Xu Y; Zhong J; Wang H; Weng M; Cheng Q; Wu Q; Sun Z; Jiang H; Zhu M; Ren Y; Xu P; Chen J; Miao C
    Oncotarget; 2016 Nov; 7(48):78726-78735. PubMed ID: 27783989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-mediated nanobubbles loaded with STAT6 siRNA inhibit TGF-β1-EMT axis in LUSC cells via overcoming the polarization of M2-TAMs.
    Shu H; Ren ZJ; Li H; Zhang Y; Yin C; Nie F
    Eur J Pharm Sci; 2024 Nov; 202():106894. PubMed ID: 39245357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
    Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
    Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
    Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
    ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
    He K; Barsoumian HB; Puebla-Osorio N; Hu Y; Sezen D; Wasley MD; Bertolet G; Zhang J; Leuschner C; Yang L; Kettlun Leyton CS; Fowlkes NW; Green MM; Hettrick L; Chen D; Masrorpour F; Gu M; Maazi H; Revenko AS; Cortez MA; Welsh JW
    Cancer Immunol Res; 2023 Apr; 11(4):486-500. PubMed ID: 36700864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes.
    Zhang L; Lin Y; Li S; Guan X; Jiang X
    Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217089. PubMed ID: 36658634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy.
    Kang Y; Yan J; Han X; Wang X; Wang Y; Song P; Su X; Rauf A; Jin X; Pu F; Zhang H
    ACS Appl Mater Interfaces; 2024 Jul; 16(28):36131-36141. PubMed ID: 38979627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatilla Saponins Inhibit Experimental Lung Metastasis of Melanoma via Targeting STAT6-Mediated M2 Macrophages Polarization.
    Yang X; Wu M; Yan X; Zhang C; Luo Y; Yu J
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175092
    [No Abstract]   [Full Text] [Related]  

  • 18. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression.
    Deng C; Huo M; Chu H; Zhuang X; Deng G; Li W; Wei H; Zeng L; He Y; Liu H; Li J; Zhang C; Chen H
    Mol Cancer; 2024 Mar; 23(1):49. PubMed ID: 38459596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
    Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
    Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
    Li Y; Shen Z; Chai Z; Zhan Y; Zhang Y; Liu Z; Liu Y; Li Z; Lin M; Zhang Z; Liu W; Guan S; Zhang J; Qian J; Ding Y; Li G; Fang Y; Deng H
    Gut; 2023 Nov; 72(12):2307-2320. PubMed ID: 37507218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.